SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001125345-22-000103
Filing Date
2022-11-03
Accepted
2022-11-03 16:02:21
Documents
14
Period of Report
2022-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20221103.htm   iXBRL 8-K 35698
2 EX-99.1 exhibit99-1earningspressre.htm EX-99.1 78321
6 MACROGENICS LOGO macrogenics20logo_jpgormat.jpg GRAPHIC 139164
  Complete submission text file 0001125345-22-000103.txt   451623

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20221103.xsd EX-101.SCH 1899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20221103_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20221103_pre.xml EX-101.PRE 12506
8 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20221103_htm.xml XML 10820
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 221357825
SIC: 2834 Pharmaceutical Preparations